401 PROFESSIONAL DRIVE, GAITHERSBURG, MD
Purchases Dogecoin Miners and Secures Renewable Energy Data Centre Site
Reverse Stock Split Approved by Shuttle Pharmaceuticals Board
2026 Annual Meeting Results - Shuttle Pharmaceuticals Holdings, Inc.
Merger Agreement Completed Between Shuttle Pharmaceuticals and United Dogecoin
Merges to Become the World’s Largest Public Dogecoin Miner, Investor Presentation
Annual Report to Security Holders
Announces $3.5 Million Public Offering
Preliminary Estimated Financial Results for Year Ended December 31, 2025
Q1
FY 2025
Q3
Q2
FY 2023
FY 2023 amended
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-1
Amended Registration Statement for Securities
Definitive Proxy Statement
PRE 14A
PRER14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Submission Upload
Correspondence
Definitive Revised Proxy Statement